| Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468) |
|---|
| 02/21/2006 | CA2283399C Pyridazinones as inhibitors of cyclooxygenase-2 |
| 02/16/2006 | WO2006015859A1 Trifluoromethyl substituted benzamides as kinase inhibitors |
| 02/16/2006 | WO2005080317A3 Therapeutic amide derivatives |
| 02/16/2006 | US20060035897 Trifluoromethyl substituted benzamides as kinase inhibitors |
| 02/16/2006 | CA2576407A1 Substituted phenylacetamides and their use as glucokinase activators |
| 02/16/2006 | CA2576254A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 02/16/2006 | CA2575316A1 Trifluoromethyl substituted benzamides as kinase inhibitors |
| 02/15/2006 | CN1735601A Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds |
| 02/15/2006 | CN1735600A 3-phenyl-cinnoline homologue and antitumor agent containing the same |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030553 Cell adhesion inhibitors |
| 02/09/2006 | CA2573124A1 Anti-inflammatory medicaments |
| 02/08/2006 | EP1265871B1 Pyridazinyl phenyl hydrazones useful against congestive heart failure |
| 02/08/2006 | EP0988045B1 Peptide nucleic acid monomers and oligomers |
| 02/08/2006 | CN1732163A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
| 02/08/2006 | CN1732156A Biphenyl derivatives and their use as fungicides |
| 02/08/2006 | CN1732154A Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
| 02/08/2006 | CN1732147A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/08/2006 | CN1240710C Method for preparing bicyclic compounds and use of said method for preparing inhibitor compound |
| 02/07/2006 | US6995261 Treatment of meningitis, septic shock, infections, reperfusion injuries, hepatitis, pancreatitis; bone, autoimmune, viral, and respiratory system disorders; antiinflammatory, antiarthritic, and antitumor agents |
| 02/02/2006 | WO2005113511A9 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/02/2006 | US20060025415 Compositions useful as inhibitors of voltage-gated sodium channels |
| 02/01/2006 | EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 01/26/2006 | WO2006009054A1 Phenethylnicotinamide compound |
| 01/26/2006 | US20060019962 Modulators of muscarinic receptors |
| 01/26/2006 | CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient |
| 01/25/2006 | EP1619186A1 Method for obtaining pure enantiomers of a pyridazinone derivative |
| 01/24/2006 | US6989447 Compounds |
| 01/24/2006 | CA2261923C Pyridazino [4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists |
| 01/24/2006 | CA2205757C Pyridazinone derivatives and their use as inhibitors of prostaglandin g/h synthase i and ii(cox i and ii) |
| 01/19/2006 | US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics |
| 01/19/2006 | DE102004031323A1 Substituierte Pyridazincarboxamide und Derivate hiervon And derivatives thereof substituted Pyridazincarboxamide |
| 01/18/2006 | EP1616576A1 Specific nad(p)h oxidase inhibitor |
| 01/12/2006 | WO2006003495A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/12/2006 | US20060009459 Antidiabetic agents; disease of glucose tolerance; insulin resistance; obesity; dyslipidemia; metabolic disorders; liver disorders |
| 01/12/2006 | CA2573193A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/11/2006 | CN1720243A Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 01/11/2006 | CN1720238A Neurologically-active compounds |
| 01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
| 01/10/2006 | CA2373395C Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors |
| 01/05/2006 | WO2004080976A8 Phthalazinone derivatives |
| 01/05/2006 | US20060004015 Fibrotic disorders; disorders characterized by harmful buildup of collagen and/or by excessive lysyl oxidase enzymatic activity |
| 01/04/2006 | EP1611121A1 Pyridazinone derivatives as cdk2-inhibitors |
| 01/04/2006 | EP1610753A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 01/04/2006 | CN1717395A Reactive materials for limited play optical devices and methods of making same |
| 01/03/2006 | US6982335 Synthesis of substituted thiazoline carboxylic acids |
| 12/29/2005 | WO2005123693A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 12/29/2005 | WO2005123692A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 12/29/2005 | WO2005122682A2 Process for the preparation of esters of piperazic acid |
| 12/29/2005 | US20050288340 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 12/29/2005 | CA2570196A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 12/29/2005 | CA2570170A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 12/28/2005 | EP1608629A1 Benzyl-pyridazinons as reverse transcriptase inhibitors |
| 12/22/2005 | WO2005121105A1 Novel 3-phenyltetrahydrocinnolin-5-ol derivative and medicinal use thereof |
| 12/22/2005 | WO2005121104A1 Pyridazine compound and use thereof |
| 12/22/2005 | US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/22/2005 | US20050282787 Synthesis of tetracyclines and analogues thereof |
| 12/22/2005 | CA2568301A1 3-phenyltetrahydrocinnolin-5-ol derivatives and medicinal use thereof of |
| 12/21/2005 | EP1606254A1 2,4,6-phenyl substituted cyclic ketoenols |
| 12/20/2005 | US6977261 Treating osteoarthritis or rheumatoid arthritis |
| 12/15/2005 | WO2005117883A1 Modulators of muscarinic receptors |
| 12/15/2005 | WO2005117876A1 Dual small molecule inhibitors of cancer and angiogenesis |
| 12/15/2005 | US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function |
| 12/15/2005 | CA2568622A1 Dual small molecule inhibitors of cancer and angiogenesis |
| 12/15/2005 | CA2568524A1 Modulators of muscarinic receptors |
| 12/14/2005 | EP1604984A1 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 12/14/2005 | CN1708478A P-(sulfonyl)-aryl and heteroaryls amines |
| 12/14/2005 | CN1231440C Novel tricyclic compound |
| 12/13/2005 | US6974815 effective as antagonists of Leukointegrins and/or ICAMs |
| 12/08/2005 | WO2005115992A1 Theramutein modulators |
| 12/08/2005 | WO2005115983A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders |
| 12/08/2005 | WO2005115972A1 Therapeutic compounds |
| 12/08/2005 | US20050272931 Vanilloid receptor ligands and their use in treatments |
| 12/08/2005 | US20050272823 improved selectivity and pharmacokinetic properties; 6-Fluoro-1-[(1 H-indazol-4-yl)amino]-4,4-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalene-2,5-diol; cyclization of imines |
| 12/08/2005 | US20050272036 Ketones |
| 12/08/2005 | DE102004017662B3 New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors |
| 12/08/2005 | CA2567813A1 Theramutein modulators |
| 12/08/2005 | CA2565066A1 Therapeutic compounds |
| 12/08/2005 | CA2564638A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders |
| 12/06/2005 | US6972297 2-Hydroxy-mutilin carbamate derivatives for antibacterial use |
| 12/06/2005 | US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines |
| 12/06/2005 | US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 12/01/2005 | WO2005113511A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 12/01/2005 | WO2005112945A2 Synthesis of tetracyclines and analogues thereof |
| 12/01/2005 | US20050267163 Vanilloid receptor ligands and their use in treatments |
| 12/01/2005 | US20050267123 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 12/01/2005 | US20050267119 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 12/01/2005 | US20050267118 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 12/01/2005 | US20050267113 Autoimmune disease; antiinflammatory agents; antiischemic agents; rheumatic diseases; antiarthritic agents; interleu |
| 12/01/2005 | US20050267102 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 11/30/2005 | EP1600442A1 Heteroarylcarbamoylbenzene derivative |
| 11/30/2005 | EP1280780B1 Asymmetric synthesis of piperazic acid and derivatives thereof |
| 11/29/2005 | US6969715 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 11/24/2005 | US20050261503 Heteroaromatic glucokinase activators |
| 11/24/2005 | US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 11/24/2005 | DE102004021779A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments |
| 11/23/2005 | EP1372645B1 Reconstitutable parenteral composition containing a cox-2 inhibitor |
| 11/17/2005 | WO2005108373A1 Novel beta agonists, method for producing the same and their use as drugs |